European Medicines Agency 'convinced' benefits of AstraZeneca vaccine outweigh risks

The regulator, which approved the AstraZeneca jab for Europe, is due to offer a further update on Thursday. File Picture: Yui Mok/PA

The European Medicines Agency is conducting a full scientific review of the Oxford/AstraZeneca vaccine, and has said it currently “remains convinced” that the “benefits of this vaccine outweigh the risk”.

The EMA said there was "no indication" that the Oxford/AstraZeneca vaccine was the cause of reported blood clots.